Hommes DW - Search Results

1

Feasibility of evaluating Crohn's disease activity at 3.0 Tesla.

van Gemert-Horsthuis K, Florie J, Hommes DW, Lavini C, Reitsma JB, van Deventer SJ, Stoker J. van Gemert-Horsthuis K, et al. Among authors: hommes dw. J Magn Reson Imaging. 2006 Aug;24(2):340-8. doi: 10.1002/jmri.20650. J Magn Reson Imaging. 2006. PMID: 16786589

2

Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease.

Florie J, Horsthuis K, Hommes DW, Nio CY, Reitsma JB, van Deventer SJ, Stoker J. Florie J, et al. Among authors: hommes dw. Clin Gastroenterol Hepatol. 2005 Dec;3(12):1221-8. doi: 10.1016/s1542-3565(05)00853-0. Clin Gastroenterol Hepatol. 2005. PMID: 16361048

3

Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease.

Horsthuis K, Ziech ML, Bipat S, Spijkerboer AM, de Bruine-Dobben AC, Hommes DW, Stoker J. Horsthuis K, et al. Among authors: hommes dw. Clin Imaging. 2011 Sep-Oct;35(5):360-5. doi: 10.1016/j.clinimag.2010.09.003. Clin Imaging. 2011. PMID: 21872125

4

Targeting tumor necrosis factor-alpha in inflammatory bowel disease: why, how, and when?

Hommes DW, van Deventer SJ. Hommes DW, et al. Curr Opin Gastroenterol. 2003 Jul;19(4):350-7. doi: 10.1097/00001574-200307000-00005. Curr Opin Gastroenterol. 2003. PMID: 15703576

5

Anti- and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's disease.

Hommes DW, van Deventer SJ. Hommes DW, et al. Curr Opin Clin Nutr Metab Care. 2000 May;3(3):191-5. doi: 10.1097/00075197-200005000-00005. Curr Opin Clin Nutr Metab Care. 2000. PMID: 10871234 Review.

6

Infliximab therapy in Crohn's disease: safety issues.

Hommes DW, van Deventer SJ. Hommes DW, et al. Neth J Med. 2003 Apr;61(4):100-4. Neth J Med. 2003. PMID: 12852717 Free article. Review.

7

Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis.

Dekker E, van den Broek FJ, Reitsma JB, Hardwick JC, Offerhaus GJ, van Deventer SJ, Hommes DW, Fockens P. Dekker E, et al. Among authors: hommes dw. Endoscopy. 2007 Mar;39(3):216-21. doi: 10.1055/s-2007-966214. Endoscopy. 2007. PMID: 17385106 Clinical Trial.

8

Endoscopy in inflammatory bowel diseases.

Hommes DW, van Deventer SJ. Hommes DW, et al. Gastroenterology. 2004 May;126(6):1561-73. doi: 10.1053/j.gastro.2004.03.023. Gastroenterology. 2004. PMID: 15168367 Review.

9

Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease.

Löwenberg M, Verhaar A, van den Blink B, ten Kate F, van Deventer S, Peppelenbosch M, Hommes D. Löwenberg M, et al. J Immunol. 2005 Aug 15;175(4):2293-300. doi: 10.4049/jimmunol.175.4.2293. J Immunol. 2005. PMID: 16081798

10

Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells.

Zelinkova Z, van Beelen AJ, de Kort F, Moerland PD, Ver Loren van Themaat E, te Velde AA, van Deventer SJ, de Jong EC, Hommes DW. Zelinkova Z, et al. Among authors: hommes dw. Inflamm Bowel Dis. 2008 Feb;14(2):186-94. doi: 10.1002/ibd.20308. Inflamm Bowel Dis. 2008. PMID: 17941075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page